- Home
- TECX vs OLMA Comparison
TECX vs OLMA Comparison
Compare TECX & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- OLMA
- Stock Information
- Founded
- TECX 2019
- OLMA 2006
- Country
- TECX United States
- OLMA United States
- Employees
- TECX N/A
- OLMA N/A
- Industry
- TECX
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- TECX
- OLMA Health Care
- Exchange
- TECX Nasdaq
- OLMA Nasdaq
- Market Cap
- TECX 334.4M
- OLMA 289.0M
- IPO Year
- TECX 2018
- OLMA 2020
- Fundamental
- Price
- TECX $21.51
- OLMA $5.28
- Analyst Decision
- TECX Buy
- OLMA Strong Buy
- Analyst Count
- TECX 6
- OLMA 4
- Target Price
- TECX $79.20
- OLMA $24.50
- AVG Volume (30 Days)
- TECX 172.8K
- OLMA 688.0K
- Earning Date
- TECX 05-08-2025
- OLMA 05-13-2025
- Dividend Yield
- TECX N/A
- OLMA N/A
- EPS Growth
- TECX N/A
- OLMA N/A
- EPS
- TECX N/A
- OLMA N/A
- Revenue
- TECX N/A
- OLMA N/A
- Revenue This Year
- TECX N/A
- OLMA N/A
- Revenue Next Year
- TECX N/A
- OLMA N/A
- P/E Ratio
- TECX N/A
- OLMA N/A
- Revenue Growth
- TECX N/A
- OLMA N/A
- 52 Week Low
- TECX $13.70
- OLMA $2.86
- 52 Week High
- TECX $61.07
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- TECX 51.42
- OLMA 60.00
- Support Level
- TECX $21.20
- OLMA $4.80
- Resistance Level
- TECX $22.75
- OLMA $5.61
- Average True Range (ATR)
- TECX 1.43
- OLMA 0.38
- MACD
- TECX 0.01
- OLMA 0.02
- Stochastic Oscillator
- TECX 41.32
- OLMA 78.71
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.